Lipids
Lipids(脂质)
- Acyl-CoAs(13)
- Cyclooxygenase(543)
- Endocannabinoid/Endocannabinoid-like(145)
- Fatty Acid Conjugates(11)
- Fatty Acids(498)
- Fatty Alcohols/Aldehydes(16)
- Fatty Amides(77)
- Fatty Esters/Ethers(152)
- Glycerolipids(357)
- Glycerophospholipids(272)
- Hydrocarbons(15)
- Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids(146)
- Isoprostanes(36)
- Leukotrienes(69)
- Lipid Transport(11)
- Lipid-Based Drug Delivery(163)
- Lipoxins/Resolvin Es(10)
- Octadecanoids(124)
- Other Lipid Kinases(2)
- P450
- Polyketides(71)
- Prenol Lipids(19)
- Prostaglandins(483)
- Protein Lipidation(24)
- Reactive O2/N2 Pathways(116)
- Saccharolipids(2)
- Sphingolipids(359)
- Sterol Lipids(288)
- Thromboxanes(14)
- 11β-HSD
- 17β-HSD(2)
Lipids 相关产品(3019)
- GC1873917-trans Prostaglandin E3CAS: 210979-33-2
PGE 3 isomer potentially derived from COX metabolism of dietary trans-fatty acids
- GC187481a,1b-dihomo Prostaglandin E1CAS: 23452-98-4
Produced from COX metabolism of 10,13,16-docosatrienoic acid
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC18680 | Lipoxin A4 methyl ester | 97643-35-1 | >95.00% | |
A lipid soluble, prodrug of LXA 4 | ||||
| GC18681 | Lipoxin B4 | 98049-69-5 | >95.00% | |
A positional isomer of LXA 4 | ||||
| GC18688 | CAY10589 | 1077626-52-8 | - | |
Dual Inhibitor of mPGES-1 and 5-LO | ||||
| GC18690 | Tridocosahexaenoin | 11094-59-0 | >99.00% | |
A triacylglycerol | ||||
| GC18691 | CAY10594 | 1130067-34-3 | - | |
CAY10594 是一种有效的磷脂酶 D2 (PLD2) 抑制剂（体外 IC50 为 140 nm，细胞内为 110 nm）。 | ||||
| GC18698 | CAY10665 | 1235543-17-5 | - | |
A stable bioisostere of the antiarrhythmic 17,18-EET | ||||
| GC18707 | Pimprinine | 13640-26-1 | - | |
An alkaloid with diverse biological activities | ||||
| GC18710 | CAY10700 | 1381846-21-4 | - | |
A selective mPGES-1 inhibitor | ||||
| GC18719 | Docosatetraenoyl Ethanolamide | 150314-35-5 | >98.00% | |
An endocannabinoid | ||||
| GC18735 | 15(R)-Prostaglandin E1 | 20897-91-0 | - | |
The “unnatural” C-15 stereoisomer of PGE 1 | ||||
| GC18737 | 8-iso Prostaglandin E1 | 21003-46-3 | >98.00% | |
An isoprostane with vasoconstrictor activity | ||||
| GC18738 | Prostaglandin E1 Ethanolamide | 210976-81-1 | - | |
The ethanolamine-amide analog of PGE 1 | ||||
| GC18739 | 17-trans Prostaglandin E3 | 210979-33-2 | - | |
PGE 3 isomer potentially derived from COX metabolism of dietary trans-fatty acids | ||||
| GC18740 | Prostaglandin E1 Alcohol | 21562-57-2 | >98.00% | |
A non-irritant bronchodilator | ||||
| GC18748 | 1a,1b-dihomo Prostaglandin E1 | 23452-98-4 | - | |
Produced from COX metabolism of 10,13,16-docosatrienoic acid | ||||
| GC18752 | 2-hydroxy Tricosanoic Acid | 2718-37-8 | - | |
A hydroxy fatty acid | ||||
| GC18753 | Prostaglandin K2 | 275816-51-8 | - | |
The 9,11-diketone formed by oxidation of PGE 2 or PGD 2 | ||||
| GC18757 | CAY10444 | 298186-80-8 | >98.00% | |
CAY10444是一种鞘氨醇-1-磷酸受体3（S1P3）拮抗剂。CAY10444能够抑制表达人类S1P3的CHO细胞中由S1P引起的钙离子释放（IC 50 值为11.6μM）。 | ||||
| GC18760 | 10(E)-Pentadecenoic Acid | 321744-58-5 | >98.00% | |
A 15-carbon monounsaturated fatty acid | ||||
| GC18767 | 15(S)-15-methyl Prostaglandin E1 | 35700-26-6 | - | |
A stable PGE 1 analog | ||||
| GC18768 | Prostaglandin E1 ethyl ester | 35900-16-4 | - | |
An esterified form of PGE 1 | ||||
| GC18774 | 16,16-dimethyl Prostaglandin F2α | 39746-23-1 | - | |
A stable PGF 2α analog | ||||
| GC18775 | Palmitoleoyl Chloride | 40426-22-0 | >98.00% | |
A derivative of palmitoleic acid | ||||
| GC18776 | 6α-hydroxy Cholesterol | 41083-73-2 | >95.00% | |
An oxysterol | ||||